The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling (Q40091284)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 May 2008

edit

Language	Label	Description	Also known as
English	The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling	scientific article published on 16 May 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

title

The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

main subject

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Motohiro Kato

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Yoshihisa Shitara

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Hitoshi Sato

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Kunihiro Yoshisue

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Masaru Hirano

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Toshihiko Ikeda

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

Yuichi Sugiyama

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

publication date

16 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

published in

Pharmaceutical Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

volume

25

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

page(s)

1891-1901

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

cites work

The intestinal first-pass metabolism of substrates of CYP3A4 and P-glycoprotein-quantitative analysis based on information from the literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of itraconazole metabolites in CYP3A4 inhibition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of methods for predicting drug-drug interactions by Monte Carlo simulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Database analyses for the prediction of in vivo drug-drug interactions from in vitro data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition and induction of cytochrome P450 and the clinical implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism-based inactivation of CYP3A by HIV protease inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18483837

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11095-008-9607-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

PubMed publication ID

18483837

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18483837

retrieved

17 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40091284&oldid=2143302286"